Programmed death ligand 1 expression in diffuse large B cell lymphoma: correlation with clinicopathological prognostic factors.
Eman Mohamad IbrahimSherine RefatShaimaa El-AshwahMaryan Waheeb FahmiAfaf Taha IbrahiemPublished in: Journal of the Egyptian National Cancer Institute (2023)
This study suggests that high PD-L1 expression in DLBCL is associated with aggressive clinicopathological features and a decreased response to R-CHOP. The level of PD-L1 expression could be an independent predictor of DFS of DLBCL. More research is mandatory to standardize the cutoff value and scoring methods.